Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "MitoEAGLE data: blood and cultured cells"

From Bioblast
Line 75: Line 75:
=== TG4.2 Cultured cells ===
=== TG4.2 Cultured cells ===
:: TG leader: [[Renner-Sattler Kathrin]] DE
:: TG leader: [[Renner-Sattler Kathrin]] DE
:: TG participants: [[Komlodi Timea]] HU, [[Krako Nina]] RS, [[Labieniec-Watala Magdalena]] PL, [[Mars Tomaz]] SI, [[Palmeira Carlos]] PT, [[Pirkmajer Sergej]] SI, [[Rustan Arild]] NO, [[Scatena Roberto]] IT, [[Wuest Rob C]] NL
:: TG participants: [[Komlodi Timea]] HU, [[Krako Nina]] RS, [[Labieniec-Watala Magdalena]] PL, [[Lopez MG|Manuela Lopez]] ES, [[Mars Tomaz]] SI, [[Palmeira Carlos]] PT, [[Pirkmajer Sergej]] SI, [[Rustan Arild]] NO, [[Scatena Roberto]] IT, [[Wuest Rob C]] NL





Revision as of 07:20, 7 October 2016


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


MitoEAGLE data: blood and cultured cells



WG4

MITOEAGLE data repository for blood cells and clutured cells


MITOEAGLE Working Groups

WG4 Project application

Description

Biopsy sampling of human muscle and fat tissue for mitochondrial studies is an invasive approach. More recently measurement of mitochondrial function in human blood cells – as well as temporary cryopreservation (Karabatsiakis 2014 Transl Psychiatry) – has become an attractive and by far less invasive alternative for mitochondrial diagnostics. Mitochondrial function of blood cells was linked with numerous diseases and metabolic conditions such as sepsis, neurodegenerative diseases, depression, hypertension, amyotrophic lateral sclerosis, and early-stage heart failure (e.g. Sjoevall 2013 Crit Care; Karabatsiakis 2014 Transl Psychiatry; Hagl 2014 J Alzheimer Dis). The use of human blood cells will thus predictably widen the applicability of respirometry in human physiology and will provide a significant stimulus for the entire field of mitochondrial medicine.
A key towards achieving comparability among data sets and the applicability of human blood cells for the evaluation of mitochondrial fitness in health and disease is the standardization of the procedures to separate or isolate blood cells, the experimental procedure for the evaluation of mitochondrial respiratory characteristics, and the format for reporting. A consensus on protocols should be reached in WG4, calling for a Workshop right at the start of the COST Action. Depending on the WG4 participants input, cell lines will be defined for which harmonization of datasets should be achieved (Fig. 2).

Management

Tasks

  1. Kick-off meeting to develop a working plan for the establishment of consensus protocols, reporting schemes, and the assignment of specific study tasks.
  2. Development of SOPs for cell separation.
  3. Development of laboratory protocols for individual blood cell types (and other cell types) for mitochondrial studies on intact and permeabilized cells.
  4. Application of SOPs in experimental studies during Short Term Scientific Missions and feeding of data into the MITOEAGLE data repository.
  5. Publication of SOPs and study results.


Milestones

  1. Consensus on protocols, reporting schemes and work assignments.
  2. Completed SOPs for cell preparation & laboratory protocols.
  3. Application study finished and data transmitted to MITOEAGLE data repository.
  4. Publication finished.

Deliverables

  1. SOPs for blood cell separation and respirometric characterisation open for the research community.
  2. MITOEAGLE data repository for comparative data evaluation, planning of future studies, data mining.
  3. Publication with a set of reference data.


WG4 Action

WG Leader

Nicoleta Moisoi, Dr. - [email protected]


WG Co-Leader

Eskil Elmer, MD, PhD - [email protected]

Participants

CountryCityContact
ArmeniaYerevanTrchounian K
AustriaInnsbruckGnaiger Erich
AustriaInnsbruckFischer Christine
AustriaInnsbruckGarcia-Souza Luiz F
AustriaInnsbruckMeszaros Andras T
AustriaInnsbruckDoerrier Carolina
AustriaInnsbruckTorres-Quesada Omar
AustriaInnsbruckKarabatsiakis Alexander
AustriaInnsbruckHoppel Florian
AustriaInnsbruckCardoso Luiza HD
BelgiumLiegeVotion Dominique-Marie
BelgiumNamurDetraux Damien
BelgiumNamurArnould Thierry
BelgiumLeuvenBird Matthew
BelgiumNamurRenard P
Bosnia and HerzegovinaTuzlaJusic Amela
Bosnia and HerzegovinaTuzlaHajrulahovic Anesa
BrazilSao PauloVerdaguer Ignasi Bofill
BrazilSao PauloDominguez-Amorocho OA
BrazilSao PauloAlencar Mayke Bezerra
BrazilSão PauloCrispim Marcell
CroatiaZagrebRubelj Ivica
Czech RepublicPragueMracek Tomas
Czech RepublicPragueElkalaf Moustafa
Czech RepublicHradec KraloveVernerova Andrea
Czech RepublicHradec KraloveMaseko Tumisang Edward
Czech RepublicVestecZobalova Renata
Czech RepublicPilsenMarkova Michaela
Czech RepublicPragueHansikova Hana
Czech RepublicPragueFisar Zdenek
Czech RepublicPilsenKuncova J
Czech RepublicPilsenKripnerova M
Czech RepublicPraguePecina Petr
Czech RepublicPrague 4Bajzikova Martina
Czech Republic and AustraliaPrague and SouthportNeuzil Jiri
Czech repHradec KraloveFalaye T
DenmarkCopenhagenRasmussen LJ
DenmarkAarhusRattan Suresh IS
DenmarkCopenhagenDesler C
DenmarkMalovHey-Mogensen M
DenmarkCopenhagen NMortensen OH
DenmarkHvidovreNehlin Jan O
EgyptCairoAli Sameh S
EgyptCairoAbdel-Rahman Engy Ali
EstoniaTallinnTruu Laura
EstoniaTartuGrellier T
EstoniaTallinnKlepinina Lyudmila
FinlandHelsinkiPirinen E
FinlandJyvaeskylaeLehti Maarit
FinlandTurkuStier Antoine
FranceParisPetit Patrice X
FranceBronRizwan Alam M
FranceBordeaux cedexMourier A
GermanyLeipzigOst Mario
GermanyRegensburgRenner-Sattler Kathrin
GermanyDuesseldorfPiel Sarah
GermanyFreising-WeihenstephanMusiol Eva
GermanyUlmHartmann C
GermanyFreisingKeppner Gloria
GermanyGiessenEckert Gunter P
GermanyNeuherbergBorchard Sabine
GermanyMunichJastroch M
GermanyHamburgSinger Dominique
GermanyUlmKolassa Iris
GermanyGießenSilaidos Carmina
GermanyDüsseldorfPrigione Alessandro
GermanyFreisingSchoettl T
GermanyBiberach an der RißNold V
GermanyUlmCalzia Enrico
GermanyFreisingFromme Tobias
GermanyDuesseldorfEckers A
GermanyMainzVujacic-Mirski Ksenija
GermanyUlmSchaefer PM
GermanyMainzKalinovic S
GermanyMagdeburgVieira Ligo Teixeira Camila
GermanyFreisingKlingenspor Martin
GreeceAthensTrougakos Ioannis P
HungaryDebrecenVerebne Tar K
HungaryBudapestTretter Laszlo
HungaryBudapestKomlodi Timea
IrelandDublinPorter Richard K
IrelandSligoMurphy J
IrelandDublinKaravyraki Marilena
IsraelRishon Le ZionHachmo Yafit
IsraelJerusalemSaada Reisch Ann
IsraelZrifinSova Marina
ItalyVeronaCalabria Elisa
ItalyBolognaGenova Maria Luisa
ItalyBolzanoPichler Irene
ItalyPadovaFernandez-Vizarra Erika
ItalyBolzanoCastelo Rueda Maria Paulina
ItalyBolzano/BozenVolani Chiara
ItalyBolognaPaterlini S
ItalyBolognaPorcelli AM
ItalyAnconaBattino Maurizio
ItalyBariAgrimi G
ItalyMilanoBottoni P
ItalyBolognaGasparre G
ItalyRomeScatena Roberto
JapanSapporoShirakawa R
LatviaRigaMakarova Elina
LatviaRigaKidere Dita
MalaysiaKuala LumpurAbdul Karim Norwahidah
MaltaMsidaVella Joanna
NetherlandsGroningenRots MG
NetherlandsWageningenKeijer Jaap
NetherlandsNijmegenKoopman Werner JH
NorwayOsloNikolic N
NorwayOsloRustan AC
NorwayOsloLund Jenny
NorwayBergenTronstad Karl Johan
NorwayOsloEide L
PalestineRamallahStiban Johnny
PolandLodzSiewiera Karolina
PolandWarsawSek Aleksandra
PolandPoznanRybacka-Mossakowska Joanna
PolandPoznanMichalak Slawomir
PolandWarsawWasilewski M
PolandKrakowKaczara P
PolandWarsawDymkowska Dorota
PolandPoznańLudziejewska A
PolandLodzWatala Cezary
PolandPoznanSwiniuch Daria
PolandLodzLabieniec-Watala Magdalena
PolandWarsawKampa Rafal Pawel
PortugalCovilhãDias Tania R
PortugalCoimbraCarvalho Eugenia
PortugalPortoBernardino RL
PortugalPortoAlves Marco G
PortugalCoimbraPereira Susana P
PortugalCantanhedePinho Sonia A
PortugalPortoBeleza Jorge
PortugalCatanhedePereira da Silva Grilo da Silva Filomena
PortugalCoimbraPalmeira Carlos
PortugalPortoCarrageta D
PortugalPortoMagalhaes Jose
PortugalPortoMartins Ana Dias
PortugalPortoCrisostomo Luis
PortugalPortoMoreira Bruno P
PortugalCantanhedeBento Guida Jose Freitas
PortugalPortoOliveira Pedro Fontes
Republic of KoreaYuseong-gu DaejeonQuang Don T
Republic of KoreaDaejeonPark SH
Republic of SerbiaBelgradePavlovic Kasja
Republic of SerbiaBelgradeKrako Jakovljevic Nina
RomaniaTimisoaraDanila Maria-Daniela
RomaniaTimisoaraLelcu Theia
RomaniaTimisoaraMuntean Danina M
RomaniaTimisoaraBetiu AM
RomaniaTimisoaraAvram Vlad F
RomaniaTimisoaraLighezan R
RussiaMoscowItkis YS
RussiaMoscowTsygankova P
RussiaMoscowKrylova T
Saudi ArabiaGizaKotb IA
SerbiaBelgradeJeremic M
SerbiaBelgradeIsakovic A
SerbiaBelgradeIvanovic Tijana
SerbiaBelgradeVukojevic M
SerbiaBelgradMarkovic Ivanka
SerbiaBelgradeMisirlic-Dencic S
SlovakiaBratislavaMaderova D
SlovakiaBratislavaNemec Michal
SlovakiaBratislavaUkropec J
SlovakiaKošiceCizmarova Beata
SlovakiaBratislavaSumbalova Zuzana
SlovakiaBratislavaUkropcova B
SloveniaLjubljanaMars T
SloveniaLjubljanaKopitar-Jerala Natasa
SloveniaLjubljanaPirkmajer Sergej
SpainBarcelonaDahdah Norma Ramon
SpainMadridDe los Rios C
SpainA CoruñaBlanco FJ
SpainBarcelonaGama Perez Pau
SpainValenciaFuertes Agudo Marina
SpainSevillaMuntane Jordi
SpainMadridCano-Abad MF
SpainMadridCadenas S
SpainBarcelonaTura Ceide O
SpainMadridMonsalve Maria
SpainSevillaBustos Matilde
SpainSalamancaAlmeida Angeles
SpainMadridLopez MG
SpainBarcelonaArago Marc
SpainBarcelonaHyrossova Petra
SpainBarcelonaSmolders V
SpainArmilla (Granada)Fernandez-Ortiz Marisol
SpainBarcelonaGil J
SpainValenciaVictor Victor Manuel
SpainOurenseReboredo-Rodriguez Patricia
SpainBarcelonaGonzalez Casacuberta I
SpainValenciaCasado Pinna Marta
SpainLleidaGonzalo Hugo
SpainBarcelonaZorzano Antonio
SpainGranadaQuiles JL
SpainBarcelonaJuarez D
SpainLleidaNogueras L
SpainArmilla, GranadaEscames Germaine
SpainA CoruñaMayan MD
SpainValenciaBorras Consuelo
SwedenLundAbliva
SwedenLundChamkha Imen
SwedenSödertäljeAlfaro-Moreno E
SwedenLundKarlsson M
SwedenLundWesterlund E
SwedenLundElmer Eskil
SwedenLundSimon Serrano Sonia
SwedenLinköpingFontes-Oliveira CC
SwedenLundLeffler M
Sweden, SELundAasander Frostner Eleonor
SwitzerlandLausanneZanou Nadege
SwitzerlandGenevaMartinou JC
The NetherlandsBT AmsterdamWuest Rob CI
TurkeyIzmirAydin HH
TurkeyAnkaraEngin Ayse Basak
TurkeyAnkaraTuncay Erkan
TurkeyIstanbulBaykal AT
TurkeyTekirdagAral Cenk
USAPhiladelphiaStarr Jonathan
USAFayettevilleRao RR
USASt LouisWelch R
USAPhiladelphiaJanowska Joanna
USAPhiladelphiaKilbaugh Todd
USABaton RougeIrving Brian A
USAOrlandoCoen Paul M
USAIowa CityBuettner Garry R
USAFayettevilleIyer Shilpa
United KingdomOxfordMakrecka-Kuka Marina
United KingdomLeicesterMoisoi Nicoleta
United KingdomBrightonMoore Anthony L
United KingdomBirminghamThakker A
United KingdomBirminghamJoanisse S
United KingdomStoke-on-TrentMcStay Gavin P
UruguayMontevideoRadi R


Task groups

TG leaders: suggestions discussed at the MitoFit Science Camp 2016 Kuehtai AT.
TG participants: listed as a summary from the feedback received.

TG4.1 Blood

TG leaders: Calabria Elisa IT / Calzia Enrico DE
TG participants: Krako Nina RS, Labieniec-Watala Magdalena PL, Lehti Maarit FI, Monsalve Maria ES, Muntean Danina M RO, Renner-Sattler Kathrin DE, Michalak Slawomir PL

TG4.2 Cultured cells

TG leader: Renner-Sattler Kathrin DE
TG participants: Komlodi Timea HU, Krako Nina RS, Labieniec-Watala Magdalena PL, Manuela Lopez ES, Mars Tomaz SI, Palmeira Carlos PT, Pirkmajer Sergej SI, Rustan Arild NO, Scatena Roberto IT, Wuest Rob C NL


Comments and discussion

  1. Dr. Ali will work within the realms of WG4 (blood and cultured cells) and potentially WG1 (protocol development) as well as WG5 (dissemination and training). He will participate in data generation, quality control, and repository efforts of protocols recommended by these working groups. Dr. Ali will contribute to training workshops and conferences that aim at defining standard procedures and terminology in the field of mitochondria physiology. - Sameh S Ali (2016).
  2. I am very interested in being part of the management committee either as a MC member for managment tasks or in working group 4 MITOEAGLE data repository for blood cells and cultured cells. I have experience in analyzing mitochondrial function in different human tissues as cultured cells and blood cells (also subsets of specific blood populations, see list of publications), muscle and isolated mitochondria. This together with my experience in organizing summer schools and conferences could be helpful as MC member taking care of management tasks. However, if you think my expertise is more helpful in working group 4, I am looking forward to support this working group. - Kathrin Renner-Sattler (2016).
  3. Specifically, we are studying mitochondrial metabolism in cancer cells. At this aim we are also participating to mt-HPP project, an Italian consortium whose target is a definition of mitochondrial proteome in health and disease. Briefly, my specific activity is to compare mitochondrial functional status with the mitochondrial proteome picture in different human cell lines. I do think that a "contact" between these two important initiatives should be useful for both. - Roberto Scatena (2016).
  4. My role in Mito-EAGLE would be mainly in WG 2 and 4, with a focus on skeletal and cardiac muscle and cultured cardiomyocytes and endothelial cells. I would particularly like to bridge the gap between the group leaders and young investigators, trying to represent the young people who are the active users of the OROBOROS equipment. This will fit in nicely with the goals in WG1. ... Major congratulations on obtaining this beautiful collaborative grant! Very glad to see this network getting the recognition it deserves! Looking forward to being part of this! - Rob C Wuest (2016).
  5. We mostly work with cultured human skeletal muscle cells, from different donor groups such as lean, obese, type 2 diabetics, as well as muscle cells from athletes. We are interested in collaboration with our cells and measurements on energy metabolism and mitochondral function. - Arild Rustan (2016).
  6. Based on your previous suggestions, with a great pleasure I will take up some managements duties, i.e. Short-Term Sicentific Missions organizations/coordinatings, and/or so on. I choose WG 4 (blood cells and cultured cells) eventually also WG 3 (other tissues than fat) but this will depend on grant funds receving(s) in the near future. ... I have just read the COST evaluation form and I congratulate you this beautiful/great success!!!! This news makes me very happy and I am proud of becoming a member of this "mitochondrial family. - Magdalena Labieniec-Watala (2016).
  7. Please, find enclosed my declaration to participate with my team in the following workgroups: WG1, WG2, WG3, WG4. We are now involved and have been in not a distant past – in studying of the following cell /tissue types:
    1. Blood cells, with particular emphasis on platelets and lymphocytes – isolated from animals and humans.
    2. Endothelial cells, fibroblasts, neurocytes (neuroblastoma), astrocytes, cancer cell lines – predominantly cultured.
    3. Hepatocytes, cardiomyocytes, cell isolated from brain – isolated from lab animals. - Cezary Watala (2016).
  8. I would like to participate in WG4 - MITOEAGLE data repository for blood cells and clutured cells. We are already working with cryopreserved PBMC from lung cancer, breast cancer and colon cancer patients. Thus, I would like to participate in WG4 tasks. - Slawomir Michalak (2016).
  9. I have already contacted the portuguese CNC to nominate me for the MC of theaction. Concerning my active participation, taking into account the type of work we do in my lab I could be included in all WGs. As you know we work with mitochondria from liver, muscle and fat, as well as cultured cells from different origins (WG2-4). The elaboration of SOPs (WG1) we can certainly contribute (see the book I edited on Mitochondrial Bioenergetics and in which you contribute a chapter). I believe that everybody can be part of the WG5, but as the coordinators of the action, you and Sandra should decide what is best for the success of the action. - Carlos Palmeira (2016).
  10. While going through MITOEAGLE pages on bioblast, I am realizing how substantial this your project is going to be and I will be happy to assist at my best and to grow as a scientist through this exciting collaboration. As stated in MITOEAGLE, I find it urgent to standardise the procedures to separate or isolate blood cells, experimental procedure for the evaluation of mitochondrial respiratory characteristics, and the format for reporting obtained data in order to exploit them toward future clinical and diagnostic application. I will be happy to share with MITOEAGLE network of experts, my experience and my data beyond the published records on evaluation of mitochondrial physiology in different cell lines in order to establish and publish SOPs, apply them during Short Term Scientific Missions and during my every-day scientific practice, as well as to feed the obtained data into the MITOEAGLE data repository. Even if I have no experience with data management and public relations on a large scale, I am ready to learn some new skills if necessary in order to answer your requests for balancing of MC members and management tasks, so feel free to contact me with any other suggestions regarding other tasks or different WGs. Please consider, that I have done 3-months training on evaluation of mitochondrial function in muscle biopsies in the OROBOROS reference lab of Prof. Roden in Germany - Nina Krako (2016).
  11. As you know, I have received the MC nomination from our CNC in Bucharest (Ms Elena Dinu) for my colleague, Rodica Lighezan and myself. My expertise is most on muscle tissue (in particular, heart) and also, liver - so I will go for WG2 if this is fine with you. However, Both my colleague and I are mostly interested in performing respirometry in blood cells (and this is what we will start to try in the near future); thus, you decide whether we can fit both of us in WG4, or only her. Also, in order to extend the Network in other Romanian cities with powerful state medical universities, Cluj-Napoca (as you know) and Tg Mures - 2 young men, Bela Kiss and Ovidiu Cotoi have been proposed as substitute members (for gender balance too). In particular, we want to jointly ”explore” the exciting fields of mitochondrial ”hidden toxicity” and dynamics, respectively since the former colleague is a toxicologist and the latter a pathologist. I wish you good luck and I am indeed happy and proud to be part of this growing network. - Danina M Muntean (2016).
  12. We work mainly on the cardiovascular system (endothelium) and in the liver, we also work with human blood cells and tissues, so we would fit bets in WG4. - Maria Monsalve (2016).
  13. Congratulations on the considerable progress with MITOEAGLE! I am keen to participate in this exciting project and I’m sure I can make a valuable contribution to it's success. I have extensive experience performing respirometry assays in human muscle biopsies, myoblasts/tubes and mouse tissues in the contexts of aging, obesity, exercise and inactivity. I feel that I could contribute to any of the five working groups, but particularly to WG2, WG4, and WG5. I am also happy and willing to serve on the Management Committee if needed. Again, congratulations on organizing such an exciting project. - Paul M Coen (2016).
  14. As research group working in the field of skeletal muscle research (development,function and regeneration, metabolic pathways, signalling, and energy metabolism and skeletal muscle in special condition-ischemia, hypoxia, sepsis) we found several topics in the COST Action particularly interesting. Indeed, we are highly interested in effects of media and protocols on experimental readouts in cell cultures (please see Pirkmajer 2011 Am J Physiol Cell Physiol and Rajh 2016 PLOS ONE). We therefore find the focus on harmonization and validation of protocols and terminology especially important. - Tomaz Mars (2016).

Projects in progress

» MitoFit-Bloodcells
» MiPMap

Next steps